Therapy of herpes simplex viral keratitis

I. S. Barequet, T. P. O'Brien*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Herpes simplex virus (HSV) eye infections are a major cause of corneal opacity and visual loss in developed countries. The successful management of HSV keratitis depends on clinical recognition of the specific tissue layers involved and the various immune components of the keratitis. Modulation of HSV ocular disease relies upon the appropriate application of antiviral and anti-inflammatory medications. The development of several antiviral drugs is discussed, and treatment outlines are given for infectious epithelial keratitis, neurotrophic keratopathy, and stromal keratitis.

Original languageEnglish
Pages (from-to)63-69
Number of pages7
JournalOphthalmology Clinics of North America
Issue number1
StatePublished - 1999
Externally publishedYes


Dive into the research topics of 'Therapy of herpes simplex viral keratitis'. Together they form a unique fingerprint.

Cite this